Surgical Embolectomy for Acute Massive and Submassive Pulmonary Embolism in a Series of 115 Patients

Pulmonary embolectomy is often indicated for central pulmonary embolism (PE) with hemodynamic instability, but remains controversial for hemodynamically stable patients with signs of right ventricular dysfunction. Because thrombolytic therapy is often contraindicated postoperatively, we reviewed ris...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:The Annals of thoracic surgery Ročník 100; číslo 4; s. 1245 - 51; discussion 1251-2
Hlavní autori: Neely, Robert C, Byrne, John G, Gosev, Igor, Cohn, Lawrence H, Javed, Quratulain, Rawn, James D, Goldhaber, Samuel Z, Piazza, Gregory, Aranki, Sary F, Shekar, Prem S, Leacche, Marzia
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Netherlands 01.10.2015
Predmet:
ISSN:1552-6259
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Pulmonary embolectomy is often indicated for central pulmonary embolism (PE) with hemodynamic instability, but remains controversial for hemodynamically stable patients with signs of right ventricular dysfunction. Because thrombolytic therapy is often contraindicated postoperatively, we reviewed risk factors and outcomes of pulmonary embolectomy for stable and unstable central PE, particularly in the early postoperative period. Between October 1999 and September 2013, 115 patients underwent pulmonary embolectomy for central, hemodynamically unstable PE (49 of 115, 43%) or hemodynamically stable PE (56 of 115, 49%). Ten operations for alternate indications (right atrial mass, endocarditis) were excluded for comparison analysis, leaving 105 patients. Mean age was 59 ± 13 years; 46 of 105 patients (44%) had recent surgery (within 5 weeks): orthopedic (12 of 46, 25%), neurosurgery (11 of 46, 24%), or general surgery (10 of 46, 22%). Preoperative demographics did not differ between groups, except for the frequency of cardiopulmonary resuscitation among unstable patients (11 of 49, 22%) versus stable patients (0 of 56, 0%; p < 0.001). Operative mortality for the combined groups was 6.6% (7 of 105): unstable 10.2% (5 of 49) versus stable 3.6% (2 of 56; p = 0.247). Of 11 patients requiring preoperative cardiopulmonary resuscitation, 4 died. Six-month, 1-year, and 3-year survival rates were, respectively, 75%, 68.4%, and 65.8% for unstable PE, and 92.6%, 86.7%, and 80.4% for stable PE (p = 0.018). This large series of pulmonary embolectomies demonstrates excellent early and late survival rates for patients with stable PE and unstable PE. These findings confirm pulmonary embolectomy as a beneficial therapeutic option for central PE, especially during the postoperative period when thrombolytic therapy is often contraindicated.
AbstractList Pulmonary embolectomy is often indicated for central pulmonary embolism (PE) with hemodynamic instability, but remains controversial for hemodynamically stable patients with signs of right ventricular dysfunction. Because thrombolytic therapy is often contraindicated postoperatively, we reviewed risk factors and outcomes of pulmonary embolectomy for stable and unstable central PE, particularly in the early postoperative period. Between October 1999 and September 2013, 115 patients underwent pulmonary embolectomy for central, hemodynamically unstable PE (49 of 115, 43%) or hemodynamically stable PE (56 of 115, 49%). Ten operations for alternate indications (right atrial mass, endocarditis) were excluded for comparison analysis, leaving 105 patients. Mean age was 59 ± 13 years; 46 of 105 patients (44%) had recent surgery (within 5 weeks): orthopedic (12 of 46, 25%), neurosurgery (11 of 46, 24%), or general surgery (10 of 46, 22%). Preoperative demographics did not differ between groups, except for the frequency of cardiopulmonary resuscitation among unstable patients (11 of 49, 22%) versus stable patients (0 of 56, 0%; p < 0.001). Operative mortality for the combined groups was 6.6% (7 of 105): unstable 10.2% (5 of 49) versus stable 3.6% (2 of 56; p = 0.247). Of 11 patients requiring preoperative cardiopulmonary resuscitation, 4 died. Six-month, 1-year, and 3-year survival rates were, respectively, 75%, 68.4%, and 65.8% for unstable PE, and 92.6%, 86.7%, and 80.4% for stable PE (p = 0.018). This large series of pulmonary embolectomies demonstrates excellent early and late survival rates for patients with stable PE and unstable PE. These findings confirm pulmonary embolectomy as a beneficial therapeutic option for central PE, especially during the postoperative period when thrombolytic therapy is often contraindicated.
BACKGROUNDPulmonary embolectomy is often indicated for central pulmonary embolism (PE) with hemodynamic instability, but remains controversial for hemodynamically stable patients with signs of right ventricular dysfunction. Because thrombolytic therapy is often contraindicated postoperatively, we reviewed risk factors and outcomes of pulmonary embolectomy for stable and unstable central PE, particularly in the early postoperative period.METHODSBetween October 1999 and September 2013, 115 patients underwent pulmonary embolectomy for central, hemodynamically unstable PE (49 of 115, 43%) or hemodynamically stable PE (56 of 115, 49%). Ten operations for alternate indications (right atrial mass, endocarditis) were excluded for comparison analysis, leaving 105 patients.RESULTSMean age was 59 ± 13 years; 46 of 105 patients (44%) had recent surgery (within 5 weeks): orthopedic (12 of 46, 25%), neurosurgery (11 of 46, 24%), or general surgery (10 of 46, 22%). Preoperative demographics did not differ between groups, except for the frequency of cardiopulmonary resuscitation among unstable patients (11 of 49, 22%) versus stable patients (0 of 56, 0%; p < 0.001). Operative mortality for the combined groups was 6.6% (7 of 105): unstable 10.2% (5 of 49) versus stable 3.6% (2 of 56; p = 0.247). Of 11 patients requiring preoperative cardiopulmonary resuscitation, 4 died. Six-month, 1-year, and 3-year survival rates were, respectively, 75%, 68.4%, and 65.8% for unstable PE, and 92.6%, 86.7%, and 80.4% for stable PE (p = 0.018).CONCLUSIONSThis large series of pulmonary embolectomies demonstrates excellent early and late survival rates for patients with stable PE and unstable PE. These findings confirm pulmonary embolectomy as a beneficial therapeutic option for central PE, especially during the postoperative period when thrombolytic therapy is often contraindicated.
Author Cohn, Lawrence H
Aranki, Sary F
Neely, Robert C
Goldhaber, Samuel Z
Gosev, Igor
Byrne, John G
Javed, Quratulain
Leacche, Marzia
Rawn, James D
Piazza, Gregory
Shekar, Prem S
Author_xml – sequence: 1
  givenname: Robert C
  surname: Neely
  fullname: Neely, Robert C
  organization: Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 2
  givenname: John G
  surname: Byrne
  fullname: Byrne, John G
  organization: Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 3
  givenname: Igor
  surname: Gosev
  fullname: Gosev, Igor
  organization: Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 4
  givenname: Lawrence H
  surname: Cohn
  fullname: Cohn, Lawrence H
  organization: Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 5
  givenname: Quratulain
  surname: Javed
  fullname: Javed, Quratulain
  organization: Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 6
  givenname: James D
  surname: Rawn
  fullname: Rawn, James D
  organization: Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 7
  givenname: Samuel Z
  surname: Goldhaber
  fullname: Goldhaber, Samuel Z
  organization: Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 8
  givenname: Gregory
  surname: Piazza
  fullname: Piazza, Gregory
  organization: Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 9
  givenname: Sary F
  surname: Aranki
  fullname: Aranki, Sary F
  organization: Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 10
  givenname: Prem S
  surname: Shekar
  fullname: Shekar, Prem S
  organization: Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 11
  givenname: Marzia
  surname: Leacche
  fullname: Leacche, Marzia
  email: mleacche@partners.org
  organization: Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: mleacche@partners.org
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26165484$$D View this record in MEDLINE/PubMed
BookMark eNo1kEtPwzAQhC0Eog_4C8hHLgm2EzvJsarKQyqiUuAc-bEBV0lcbAep_56gltNoR9-udmaBLgc3AEKYkpQSKh72qYxfzksdRp8yQnlKspRSeoHmlHOWCMarGVqEsCeEsMm6RjMmqOB5mc-RqUf_abXs8KZXrgMdXX_ErfN4pccI-FWGYH8Ay8HgelT9edyNXe8G6Y-nNRt6bAcscQ3eQsCuxZRyvJPRwhDDDbpqZRfg9qxL9PG4eV8_J9u3p5f1apvo6dGYCAOMCK1YUWngmoscMm1ULsG0qihKLnMQLVNGMV0ZLrXiUBWFKIGUJckytkT3p7sH775HCLHpbdDQdXIAN4aGFrTKGcnoH3p3RqdQYJqDt_0Up_lvhv0CckVppg
CitedBy_id crossref_primary_10_1055_s_0042_1755573
crossref_primary_10_1007_s11886_023_01891_w
crossref_primary_10_1097_MCP_0000000000000897
crossref_primary_10_1055_s_0041_1722868
crossref_primary_10_1016_j_athoracsur_2020_01_075
crossref_primary_10_1161_CIR_0000000000001117
crossref_primary_10_1016_j_jacc_2020_06_065
crossref_primary_10_1182_blood_2016_11_693663
crossref_primary_10_1016_j_suc_2022_02_004
crossref_primary_10_1093_eurheartj_ehac270
crossref_primary_10_1097_imi_0000000000000439
crossref_primary_10_1016_j_clinimag_2021_08_017
crossref_primary_10_1111_jocs_13576
crossref_primary_10_1016_j_jtcvs_2017_10_045
crossref_primary_10_1186_s13019_020_01364_z
crossref_primary_10_1055_a_2215_9003
crossref_primary_10_1016_j_athoracsur_2016_11_016
crossref_primary_10_1016_j_jvsv_2021_02_015
crossref_primary_10_1055_s_0042_1756176
crossref_primary_10_1016_j_jtcvs_2017_11_040
crossref_primary_10_1111_jocs_14652
crossref_primary_10_1002_anbr_202400112
crossref_primary_10_1148_rg_220026
crossref_primary_10_1177_0300060519850399
crossref_primary_10_1016_j_jtcvs_2017_10_139
crossref_primary_10_1016_j_athoracsur_2018_10_035
crossref_primary_10_1183_13993003_01773_2018
crossref_primary_10_1016_j_athoracsur_2017_08_033
crossref_primary_10_1053_j_semtcvs_2021_06_011
crossref_primary_10_1177_1358863X17730430
crossref_primary_10_1007_s10554_019_01567_z
crossref_primary_10_1155_2022_3562017
crossref_primary_10_1177_1076029618812954
crossref_primary_10_1161_CIRCULATIONAHA_115_015916
crossref_primary_10_1177_155698451701200606
crossref_primary_10_1016_j_jtcvs_2018_06_032
crossref_primary_10_1093_ejcts_ezw297
crossref_primary_10_1148_radiol_2017151978
crossref_primary_10_1016_j_jemermed_2020_09_041
crossref_primary_10_1016_j_jvsv_2020_04_033
crossref_primary_10_3390_jcdd12010012
crossref_primary_10_1016_j_athoracsur_2020_02_024
crossref_primary_10_1016_j_jtcvs_2018_05_085
crossref_primary_10_1016_j_amjcard_2015_12_041
crossref_primary_10_1093_omcr_omad033
crossref_primary_10_3390_jcm11164734
crossref_primary_10_1080_14779072_2017_1337509
crossref_primary_10_1007_s42399_025_01783_w
crossref_primary_10_1007_s00134_025_07805_4
crossref_primary_10_1007_s11239_020_02189_2
crossref_primary_10_1186_s13054_021_03679_2
crossref_primary_10_1016_j_anclin_2022_11_002
crossref_primary_10_1016_j_ijcard_2016_03_141
crossref_primary_10_5761_atcs_ra_19_00158
crossref_primary_10_1016_j_iccl_2017_08_002
crossref_primary_10_1164_rccm_201711_2302CI
crossref_primary_10_1016_j_ccm_2018_04_017
crossref_primary_10_1016_j_acvd_2020_06_002
crossref_primary_10_1093_ejcts_ezx232
crossref_primary_10_1007_s40137_021_00293_7
crossref_primary_10_1111_ans_16284
crossref_primary_10_1016_j_avsg_2021_05_057
crossref_primary_10_1136_bcr_2022_249225
crossref_primary_10_1177_23247096231166673
crossref_primary_10_1002_ccd_30745
crossref_primary_10_1016_j_athoracsur_2018_02_079
crossref_primary_10_1002_rth2_12216
crossref_primary_10_1093_jscr_rjac528
crossref_primary_10_1177_1076029619853037
crossref_primary_10_1093_bja_el_13972
crossref_primary_10_1016_j_jscai_2022_100548
crossref_primary_10_1007_s11886_018_1084_6
crossref_primary_10_23736_S0021_9509_24_12931_X
crossref_primary_10_1016_j_rmr_2019_05_004
crossref_primary_10_1016_j_jtcvs_2018_02_107
crossref_primary_10_1007_s00059_019_4801_z
crossref_primary_10_1161_CIRCINTERVENTIONS_123_013406
crossref_primary_10_1016_j_carrev_2019_12_020
crossref_primary_10_1016_j_jtcvs_2017_10_115
crossref_primary_10_3390_jcm11164807
crossref_primary_10_3390_jcm13144076
crossref_primary_10_1111_jocs_14759
crossref_primary_10_1513_AnnalsATS_201706_467FR
ContentType Journal Article
Copyright Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.athoracsur.2015.03.111
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 1552-6259
EndPage 51; discussion 1251-2
ExternalDocumentID 26165484
Genre Journal Article
GroupedDBID ---
--K
.1-
.55
.FO
.GJ
0R~
1B1
1P~
1~5
23M
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
6J9
7-5
71M
AAEDT
AAEDW
AAEJM
AALRI
AAQFI
AAQQT
AAQXK
AAXUO
ABJNI
ABLJU
ABMAC
ABOCM
ABWVN
ACGFO
ACGFS
ACIUM
ACRPL
ACVFH
ADBBV
ADCNI
ADMUD
ADNMO
AENEX
AEUPX
AEVXI
AFCTW
AFFNX
AFPUW
AFRHN
AFTJW
AGCQF
AGHFR
AGQPQ
AI.
AIGII
AITUG
AJJEV
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
ASPBG
AVWKF
AZFZN
BAWUL
BELOY
C5W
CGR
CS3
CUY
CVF
DIK
E3Z
EBS
ECM
EFJIC
EFKBS
EIF
EJD
F5P
FDB
FEDTE
FGOYB
GBLVA
GX1
HVGLF
HZ~
IH2
IHE
J1W
J5H
K-O
KOM
L7B
M41
MO0
N9A
NPM
NQ-
O9-
OA-
OK1
OL.
OVD
P2P
P6G
PC.
R2-
RIG
ROL
RPZ
SES
SSZ
TEORI
TR2
UDS
UNMZH
UV1
VH1
W8F
X7M
XH2
XPP
Z5R
ZGI
ZXP
7X8
ID FETCH-LOGICAL-c552t-6de206cb279ce5c564e3cdb4aedfb7785a4e6f2bdb2c9d5acb5e97768e0880332
IEDL.DBID 7X8
ISICitedReferencesCount 99
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000362288000029&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
IngestDate Sat Sep 27 18:49:25 EDT 2025
Mon Jul 21 06:02:29 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c552t-6de206cb279ce5c564e3cdb4aedfb7785a4e6f2bdb2c9d5acb5e97768e0880332
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 26165484
PQID 1719420313
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1719420313
pubmed_primary_26165484
PublicationCentury 2000
PublicationDate 2015-10-01
PublicationDateYYYYMMDD 2015-10-01
PublicationDate_xml – month: 10
  year: 2015
  text: 2015-10-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle The Annals of thoracic surgery
PublicationTitleAlternate Ann Thorac Surg
PublicationYear 2015
SSID ssj0002155
Score 2.4969816
Snippet Pulmonary embolectomy is often indicated for central pulmonary embolism (PE) with hemodynamic instability, but remains controversial for hemodynamically stable...
BACKGROUNDPulmonary embolectomy is often indicated for central pulmonary embolism (PE) with hemodynamic instability, but remains controversial for...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1245
SubjectTerms Aged
Contraindications
Embolectomy - adverse effects
Female
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Postoperative Complications - epidemiology
Pulmonary Embolism - diagnostic imaging
Pulmonary Embolism - drug therapy
Pulmonary Embolism - mortality
Pulmonary Embolism - physiopathology
Pulmonary Embolism - surgery
Retrospective Studies
Risk Factors
Thrombolytic Therapy
Tomography, X-Ray Computed
Treatment Outcome
Title Surgical Embolectomy for Acute Massive and Submassive Pulmonary Embolism in a Series of 115 Patients
URI https://www.ncbi.nlm.nih.gov/pubmed/26165484
https://www.proquest.com/docview/1719420313
Volume 100
WOSCitedRecordID wos000362288000029&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7UevDiA1_1xQpeg81mN9ucRKTFS0tAhd7CPiZQMEltGqH_3tlkS0-C4CUQwiZhdvbbb2aHbwh50CzJVQIxxiZCBFxENtAs0kEOluVMDoWKdNtsQk6nw9ksSX3CrfZllRtMbIHaVsblyB9DieE2c0qDT4uvwHWNcqervoXGLunhg8R5tZxt1cJxOxO-eqer6UJShYY1deOUQEPh5E3DMPydXLabzPjov793TA49vaTPnT-ckB0oT4l9a5YtwNFRoas2T1-sKbJV-myaFdAJEmgEPapKSxFICn-bNp_4VrVcd8PmdUHnJVXUJdSgplVOkefRtBNmrc_Ix3j0_vIa-O4KgRGCrYLYAhvERjOZGBBGxBwiYzVXYHMt3SxxiHOmrWYmsUIZLQDJYjwEBKZBFLFzsldWJVwSqvFzRoCxA5ZwrhG3JFiplUB-GXGh-uR-Y7QMvdcdSagSqqbOtmbrk4vO8tmik9nIMLZzTe351R9GX5MDN6Fdld0N6eW4duGW7Jvv1bxe3rVugddpOvkBRjPFUw
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Surgical+Embolectomy+for+Acute+Massive+and+Submassive+Pulmonary+Embolism+in+a+Series+of+115+Patients&rft.jtitle=The+Annals+of+thoracic+surgery&rft.au=Neely%2C+Robert+C&rft.au=Byrne%2C+John+G&rft.au=Gosev%2C+Igor&rft.au=Cohn%2C+Lawrence+H&rft.date=2015-10-01&rft.eissn=1552-6259&rft.volume=100&rft.issue=4&rft.spage=1245&rft.epage=51%3B+discussion+1251-2&rft_id=info:doi/10.1016%2Fj.athoracsur.2015.03.111&rft.externalDBID=NO_FULL_TEXT